Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2000 of 2051 entries
View as:

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

Phase: N/A Priority: Normal
NCT ID: NCT00411749 Org: User:
Start: 12/11/06 End: 09/18/09 Due: 09/18/10

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Phase: N/A Priority: Normal
NCT ID: NCT03259087 Org: User:
Start: 09/01/17 End: 02/09/18 Due: 02/09/19

Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)

Phase: N/A Priority: Normal
NCT ID: NCT02728089 Org: User:
Start: 04/14/16 End: 09/05/17 Due: 09/05/18

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00074529 Org: User:
Start: 10/31/03 End: 01/31/06 Due: 01/31/07

Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016)

Phase: N/A Priority: Normal
NCT ID: NCT05289271 Org: User:
Start: 03/25/22 End: 08/30/22 Due: 08/30/23

A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

Phase: N/A Priority: Normal
NCT ID: NCT05347225 Org: User:
Start: 06/09/22 End: 04/30/27 Due: 04/30/28

MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)

Phase: N/A Priority: Normal
NCT ID: NCT05494736 Org: User:
Start: 11/17/22 End: 01/31/24 Due: 01/31/25

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

Phase: N/A Priority: Normal
NCT ID: NCT03834506 Org: User:
Start: 05/02/19 End: 07/18/23 Due: 07/18/24

Rotavirus Efficacy and Safety Trial (REST)(V260-006)

Phase: N/A Priority: Normal
NCT ID: NCT00090233 Org: User:
Start: 01/31/01 End: 10/31/04 Due: 10/31/05

An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)

Phase: N/A Priority: Normal
NCT ID: NCT01357135 Org: User:
Start: 07/15/09 End: 08/31/13 Due: 08/31/14

Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007)

Phase: N/A Priority: Normal
NCT ID: NCT05136690 Org: User:
Start: 04/27/22 End: 11/04/22 Due: 11/04/23

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Phase: N/A Priority: Normal
NCT ID: NCT01245738 Org: User:
Start: 08/31/10 End: 12/31/12 Due: 12/31/13

Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00378599 Org: User:
Start: 05/31/06 End: 07/31/09 Due: 07/31/10

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

Phase: N/A Priority: Normal
NCT ID: NCT01813552 Org: User:
Start: 02/28/13 End: 03/31/13 Due: 03/31/14

A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)

Phase: N/A Priority: Normal
NCT ID: NCT01155466 Org: User:
Start: 07/14/10 End: 12/20/12 Due: 12/20/13

Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)

Phase: N/A Priority: Normal
NCT ID: NCT00559468 Org: User:
Start: 12/07/06 End: 03/02/07 Due: 03/02/08

A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)

Phase: N/A Priority: Normal
NCT ID: NCT00819039 Org: User:
Start: 01/26/09 End: 03/12/13 Due: 03/12/14

Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00781846 Org: User:
Start: 10/31/08 End: 02/28/10 Due: 02/28/11

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Phase: N/A Priority: Normal
NCT ID: NCT03631784 Org: User:
Start: 10/19/18 End: 03/19/24 Due: 03/19/25

A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)

Phase: N/A Priority: Normal
NCT ID: NCT01986855 Org: User:
Start: 12/02/13 End: 09/28/16 Due: 09/28/17

MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)

Phase: N/A Priority: Normal
NCT ID: NCT05335005 Org: User:
Start: 05/30/22 End: 02/14/23 Due: 02/14/24

Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)

Phase: N/A Priority: Normal
NCT ID: NCT00723892 Org: User:
Start: 07/31/05 End: 05/31/09 Due: 05/31/10

Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)

Phase: N/A Priority: Normal
NCT ID: NCT00727259 Org: User:
Start: 10/31/04 End: 04/30/08 Due: 04/30/09

Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)

Phase: N/A Priority: Normal
NCT ID: NCT00705614 Org: User:
Start: 07/31/03 End: 02/28/13 Due: 02/28/14

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092365 Org: User:
Start: 04/01/03 End: 11/01/03 Due: 11/01/04